Clinical features of skin lesions in patients with diabetes mellitus


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Diabetes mellitus (DM) is considered a modern epidemic disease, which affects about 8.3% of the adult population, which is 382 million people in the world. Currently, dozens of types of dermatoses have been described, either preceding diabetes or developing against the background of the disease. The most common dermatoses are diabetic dermopathy, necrobiosis lipoidosis, benign acanthosis nigricans, and skin xerosis. In turn, rarely verified nosological forms include diabetic blisters, Huntley papules, palmar-plantar diabetic angiodermatitis, and acquired reactive perforating dermatosis. Patients with poorly controlled or undiagnosed diabetes mellitus are more prone to bacterial and fungal skin infections. The most common infections are staphylococcal pyoderma, erythrasma, and candidiasis. It is known that in diabetes mellitus accumulation of end products of glycation occurs, which can contribute to premature skin aging and is of great clinical importance. In this review, we tried to summarize the literature data on various skin conditions encountered in diabetes, and tried to create a detailed classification.

Full Text

Restricted Access

About the authors

Elena V. Svechnikova

Polyclinic № 1 Department of Presidential Affairs of the Russian Federation; Novosibirsk State Medical University

Email: elene-elene@bk.ru
Dr. Sci. (Med.), Head of the Department of Dermatology and Venereology and Cosmetology; Professor of the Department of Dermatovenerology and Cosmetology 26/28, Sivtsev Vrazhek lane, Moscow 119002, Russian Federation

S. G Lykova

Novosibirsk State Medical University

Novosibirsk, Russia

O. B Nemchaninova

Novosibirsk State Medical University

Novosibirsk, Russia

M. A Morzhanaeva

Novosibirsk State Medical University

Novosibirsk, Russia

References

  1. Результаты реализации подпрограммы «Сахарный диабет» Федеральной целевой программы «Предупреждение и борьба с социально значимыми заболеваниями 2007-2012 годы». Под ред. И.И. Дедова, М.В. Шестаковой. Сахарный диабет. Спецвыпуск. 2013. С. 2-46.
  2. Braverman I.M. Skin signs of systemic disease. 3d ed. Philadelphia: Saunders, 1998.
  3. Olerud J. Diabetes and the skin. In: Porte D. Jr, Sherwin R.S., eds. Ellenberg and Rifkin's Diabetes mellitus. 5th ed. Stamford, Conn.: Appleton & Lange, 1997. Р 1207-25.
  4. Muller S.A., Winkelmann R.K. Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases. Arch. Dermatol. 1966;93:272-81.
  5. Choudry K., Charles-Holmes R. Are patients with localized nodular granuloma annulare more likely to have diabetes mellitus? Clin Exp Dermatol. 2000;25:451.
  6. Машкиллейсон А.Л., Перламутров Ю.Н. Кожные изменения при сахарном диабете. Вестник дерматологии и венерологии. 1989;(5):29-31.
  7. Diris N., Colomb M., Leymarie F., et al. Non infectious skin conditions associated with diabetes mellitus: a prospective study of 308 cases. Ann Dermatol Venereol. 2003;130(11):1009-14.
  8. Frost D., Beischer W. Limited joint mobility in type 1 diabetic patients. Diab Care. 2001;24(1):95-9.
  9. Abate M., Schiavone C., Pelotti P., Salini V. Limited joint mobility in diabetes and ageing: recent advances in pathogenesis and therapy: SAGE Publications Sage UK. London, England, 2010.
  10. Cole G.W, Headley J., Skowsky R. Scleredema diabeticorum: A common and distinct cutaneous manifestation of diabetes mellitus. Diab Care. 1983;6:189.
  11. Guarneri C., Guarneri F., Borgia F., Vaccaro M. Finger pebbles in a diabetic patient: Huntley's papules. Int J Dermatol. 2005;44(9):755-56.
  12. Hermanns-L.T., Scheen A., Piérard G.E. Acanthosis nigricans associated with insulin resistance. Am J Clin Dermatol. 2004;5(3):199-203.
  13. Margolis J. Letter: Skin tags in diabetes mellitus. N Engl J Med. 1976;294:1184.
  14. Cantwell A., Martz W. Idiopathic bullae in diabetics. Arch Dermatol. 1967;96:42-4.
  15. Bristow I. Non-ulcerative skin pathologies of the diabetic foot. Diab Metab Res Rev. 2008; 24(Suppl. 1).
  16. Burrows N.P., Lovell C.R. Disorders of connective tissue. In: Rook's Textbook of Dermatology. T. Burns, S. Breathnach, N. Cox, ed. 8th edition. Wiley-Blackwell, Ltd., 2010;45:54-6.
  17. Pavlovic M.D., Milenkovic T., Dinic M., et al. The prevalence of cutaneous manifestations in young patients with type 1 diabetes. Diab Care. 2007;30:1964-67.
  18. Sanad E.M., ElFangary M.M., Sorour N.E., ElNemisy N.M. Skin manifestations in Egyptian diabetic patients: a case series study. Egypt J Dermatol Venereol. 2013;33:56-62.
  19. Sanli H, Akay B.N., Sen B.B., et al. Acquired ichthyosis associated with type 1 diabetes mellitus. Dermatoendocrinol. 2009;1(1):34-6.
  20. Namazi M.R., Jorizzo J.L., Fallahzadeh M.K. Rubeosis faciei diabeticorum: A common, but often unnoticed, clinical manifestation of diabetes mellitus. Sci World J. 2010;10:70-1.
  21. Serrao R, Zirwas M., English J.C. Palmar erythema. Am J Clin Dermatol. 2007;8(6):347-56.
  22. Beisswenger P.J., Moore L.L., Curphey T.J., et al. Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes. Diab. Care. 1993;16(5):689-94.
  23. Wagner G, Sachse M.M. Acquired reactive perforating dermatosis. J Dtsch. Dermatol Ges. 2013;8:723-30.
  24. Bustan R.S., Wasim D., Yderstraede K.B., Bygum A. Specific skin signs as a cutaneous marker of diabetes mellitus and the prediabetic state - a systematic review. Dan Med J. 2017;64(1).
  25. Yosipovitch G., Tur E., Cohen O., Rusecki Y. Skin surface pH in intertriginous areas in NIDDM patients: possible correlation to candidal intertrigo. Diab Care. 1993;16(4):560-63.
  26. Sämann A., Tajiyeva O., Müller N., et al. Prevalence of the diabetic foot syndrome at the primary care level in Germany: a cross-sectional study. Diab Med. 2008;25(5):557-63.
  27. Лимаренко М.П. Кожные проявления сахарного диабета у детей. Российский вестник перинатологии и педиатрии. 2017;62(2):17-21.
  28. Richardson T., Kerr D. Skin-related complications of insulin therapy. Am J Clin Dermatol. 2003;4(10):661-67.
  29. Кубанова А.А., Карамова А.Э., Кубанов А.А. Поиск мишеней для таргетной терапии аутоиммунных заболеваний в дерматологии. Вестник РАМН. 2015;70(2):159-64
  30. Кубанов А.А. Современные методы терапии истинной акантолитической пузырчатки. Вестник дерматологии и венерологии. 2014;4:19-27
  31. Сурдина Э.Д., Цимбалистов А.В., Кравчук Ю.А., Каспина А.И. Современные представления о ведущих факторах развития и лечении красного плоского лишая с проявлениями на слизистой оболочке рта. Вестник Санкт-Петербургского университета. Серия 11: Медицина. 2011;4:112-18.
  32. Наумова В.Н., Маслак Е.Е. Сахарный диабет и стоматологическое здоровье: проблемы диагностики и лечения пациентов стоматологических клиник. Практическая медицина. 2013;4(72):10-4.
  33. Haus J.M., Carrithers J.A., Trappe S.W., Trappe TA. Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. J Appl Physiol. 2007;103:2068-76.
  34. Verzijl N., DeGroot J., Oldehinkel E., et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J. 2000;350:381-87.
  35. DeGroot J., Verzijl N., Wenting-Van Wijk M.J., et al. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinasemediated degradation: the role of advanced glycation end products. Arthr Rheum. 2001;1 1:2562-71.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies